Skip to main content
JDRS · Open access journal

Original Article · Open access

Fracture healing potential of tetracalcium phosphate: An experimental study in a rat femur standardized diaphyseal osteotomy with open approach

PDF Cite this article

Bilal Karabak

Department of Orthopedics and Traumatology, Erzurum City Hospital, Erzurum, Türkiye

ORCID: 0000-0003-3134-8731

Yusuf Sait Durak

Department of Orthopedics and Traumatology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye

ORCID: 0000-0002-5438-5394

Orhan Karsan

Department of Orthopedics and Traumatology, Atatürk University Faculty of Medicine, Erzurum, Türkiye

ORCID: 0000-0002-5395-1497

Kutsi Tuncer

Department of Orthopedics and Traumatology, Altınbaş University, Medical Park Bahçelievler Hospital, İstanbul, Türkiye

ORCID: 0000-0002-7544-2554

Cemil Bayram

Department of Pharmacology and Toxicology, Atatürk University Faculty of Veterinary Medicine, Erzurum, Türkiye

ORCID: 0000-0001-8940-8560

Selma Sezen

Department of Pharmacology, Ağrı İbrahim Çeçen University Faculty of Medicine, Ağrı, Türkiye

ORCID: 0000-0001-6575-6149

Ufuk Okkay

Department of Pharmacology, Atatürk University Faculty of Medicine, Erzurum, Türkiye

ORCID: 0000-0002-2871-0712

Abstract

Objectives: This study aims to evaluate the impact of tetracalcium phosphate (TTCP) applied directly to the fracture line in a rat femur fracture model.

Materials and methods: Thirty-three male Sprague-Dawley rats weighing 350 to 400 g were randomly and equally divided into three groups: normal control (NC), fracture control (PC), and TTCP treatment group. Standardized femur fractures were created in the PC and TTCP groups and fixed using intramedullary Kirschner wires. In the TTCP group, TTCP dissolved in distilled water was applied directly to the fracture line. All rats were sacrificed on postoperative Day 28. Radiological, histopathological, and biochemical analyses were performed to assess fracture healing.

Results: Radiological scoring revealed significantly higher fracture healing in the TTCP group compared to the PC group on Days 14 and 28 (p<0.05). Histopathological analyses showed reduced inflammation and fibrosis, and increased chondrocyte activity and neovascularization in the TTCP group. On Day 28, serum tumor necrosis factor-alpha (TNF-α) levels were significantly higher in the PC group compared to TTCP and NC, while TTCP values were comparable to NC. No adverse tissue reactions were observed in any group.

Conclusion: The TTCP enhances fracture healing when applied directly to the fracture line, without causing soft tissue irritation or histologically detectable adverse reactions. Its biological activity and ease of application suggest that TTCP may be a promising adjunct in the treatment of complex fractures.

Declarations

Author Contributions

Idea/concept, B.K., K.T.; Design, writing the article, references and fundings: B.K.; Control/supervision, critical review: B.K., O.K.; Data collection and/or processing: B.K., S.S.; Analysis and/or interpretation: B.K., C.B.; Literature review: B.K., Y.S.D.; Materials: B.K., U.O.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.

Acknowledgments

The authors would like to thank Atatürk University Scientific Research Projects Unit for their valuable support (Project code: TTU-2022-10243). The knowledge and technical support provided during this research were greatly appreciated.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Hart NH, Newton RU, Tan J, Rantalainen T, Chivers P, Siafarikas A, et al. Biological basis of bone strength: anatomy, physiology and measurement. J Musculoskelet Neuronal Interact 2020;20:347-71.
  2. Yildirim B, Erturk C, Buyukdogan H, Saritas TB, Yildirim Erdogan N, Ertem F. Effect of N-acetylcysteine on fracture healing in rat femoral diaphysis: A histopathological, radiological, and biomechanical analysis. Jt Dis Relat Surg 2025;36:283-92. DOI: 10.52312/jdrs.2025.1975.
  3. Açan AE, Aydın ME, Bulmuş Ö, Özcan E, Karakılıç A, Turan G, et al. Irisin and its role in fracture healing: A comparative study with hyaluronic acid and platelet-rich plasma in a rat model. Jt Dis Relat Surg 2025;36:328-39. DOI: 10.52312/jdrs.2025.2097.
  4. Lichte P, Pape HC, Pufe T, Kobbe P, Fischer H. Scaffolds for bone healing: Concepts, materials and evidence. Injury 2011;42:569-73. DOI: 10.1016/j.injury.2011.03.033.
  5. Gu Y, Zhuang R, Xie X, Bai Y. Osteogenic stimulation of human dental pulp stem cells with self-setting biphasic calcium phosphate cement. J Biomed Mater Res B Appl Biomater 2020;108:1669-78. DOI: 10.1002/jbm.b.34512.
  6. Kirillova A, Kelly C, von Windheim N, Gall K. Bioinspired mineral-organic bioresorbable bone adhesive. Adv Healthc Mater 2018;7:e1800467. DOI: 10.1002/adhm.201800467.
  7. Mohseni M, Jahandideh A, Abedi G, Akbarzadeh A, Hesaraki S. Assessment of Tricalcium Phosphate/Collagen (TCP/collagene)nanocomposite scaffold compared with Hydroxyapatite (HA) on healing of segmental femur bone defect in rabbits. Artif Cells Nanomed Biotechnol 2018;46:242-9. DOI: 10.1080/21691401.2017.1324463.
  8. De Long WG Jr, Einhorn TA, Koval K, McKee M, Smith W, Sanders R, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 2007;89:649-58. DOI: 10.2106/JBJS.F.00465.
  9. Chow LC, Markovic M, Frukhtbeyn SA, Takagi S. Hydrolysis of tetracalcium phosphate under a nearconstant-composition condition--effects of pH and particle size. Biomaterials 2005;26:393-401. DOI: 10.1016/j.biomaterials.2004.02.039.
  10. Flecknell P. Laboratory animal anaesthesia. 4th ed. London: Academic Press; 2015.
  11. Safali S, Aydin BK, Nayman A, Ugurluoglu C. Effect of curcumin on bone healing: An experimental study in a rat model of femur fracture. Injury 2019;50:1915-20. DOI: 10.1016/j.injury.2019.09.002.
  12. Kuzuca BC, Doral MN, Mangiavini L, Sapmaz E, Maffulli N, Koken M. Investigation into the effect of epidermal growth factor and hyaluronic acid on fracture healing in a rat femoral fracture model. Acta Orthop Traumatol Turc 2023;57:229-36. DOI: 10.5152/j.aott.2023.22163.
  13. Indrekvam K, Gjerdet NR, Engesaeter LB, Langeland N. Effects of intramedullary reaming and nailing of rat femur. A mechanical and chemical study. Acta Orthop Scand 1991;62:582-6. DOI: 10.3109/17453679108994501.
  14. Bundkirchen K, Macke C, Reifenrath J, Schäck LM, Noack S, Relja B, et al. Severe hemorrhagic shock leads to a delayed fracture healing and decreased bone callus strength in a mouse model. Clin Orthop Relat Res 2017;475:2783-94. DOI: 10.1007/s11999-017-5473-8.
  15. Histing T, Garcia P, Holstein JH, Klein M, Matthys R, Nuetzi R, et al. Small animal bone healing models: Standards, tips, and pitfalls results of a consensus meeting. Bone 2011;49:591-9. DOI: 10.1016/j.bone.2011.07.007.
  16. Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am 1987;18:213-25.
  17. Klopfleisch R. Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res 2013;9:123. DOI: 10.1186/1746-6148-9-123.
  18. Meimandi-Parizi A, Oryan A, Bigham-Sadegh A, Sayahi E. Effects of chitosan scaffold along with royal jelly or bee venom in regeneration of critical sized radial bone defect in rat. Iran J Vet Res 2018;19:246-54.
  19. Claes LE, Heigele CA. Magnitudes of local stress and strain along bony surfaces predict the course and type of fracture healing. J Biomech 1999;32:255-66. DOI: 10.1016/s0021-9290(98)00153-5.
  20. Tsai CH, Ju CP, Chern Lin JH. Morphology and mechanical behavior of TTCP-derived calcium phosphate cement subcutaneously implanted in rats. J Mater Sci Mater Med 2008;19:2407-15. DOI: 10.1007/s10856-006-0055-4.
  21. Marongiu G, Dolci A, Verona M, Capone A. The biology and treatment of acute long-bones diaphyseal fractures: Overview of the current options for bone healing enhancement. Bone Rep 2020;12:100249. DOI: 10.1016/j.bonr.2020.100249.
  22. Xu HH, Weir MD, Simon CG. Injectable and strong nanoapatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater 2008;24:1212-22. DOI: 10.1016/j.dental.2008.02.001.
  23. Tsai CH, Lin RM, Ju CP, Chern Lin JH. Bioresorption behavior of tetracalcium phosphate-derived calcium phosphate cement implanted in femur of rabbits. Biomaterials 2008;29:984-93. DOI: 10.1016/j.biomaterials.2007.10.014.
  24. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000;371:10-27.
  25. Karnes JM, Daffner SD, Watkins CM. Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone 2015;78:87-93. DOI: 10.1016/j.bone.2015.05.001.
  26. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001;16:1004-14. DOI: 10.1359/jbmr.2001.16.6.1004.
  27. Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008;14:179-86. DOI: 10.1089/ten.teb.2008.0038.
  28. Marsell R, Einhorn TA. The biology of fracture healing. Injury 2011;42:551-5. DOI: 10.1016/j.injury.2011.03.031.
  29. Poon B, Kha T, Tran S, Dass CR. Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls. J Pharm Pharmacol 2016;68:139-47. DOI: 10.1111/jphp.12506.
  30. Hara Y, Ghazizadeh M, Shimizu H, Matsumoto H, Saito N, Yagi T, et al. Delayed expression of circulating TGF-β1 and BMP-2 Levels in human nonunion long bone fracture healing. J Nippon Med Sch 2017;84:12-18. DOI: 10.1272/jnms.84.12.
  31. Einhorn TA, Majeska RJ, Mohaideen A, Kagel EM, Bouxsein ML, Turek TJ, et al. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 2003;85:1425-35. DOI: 10.2106/00004623-200308000-00002.